Form 4: Exagen CEO Sells Shares for Tax Obligations

Exagen Inc.'s President and CEO, John Aballi, sold 11,430 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• John Aballi, President and CEO of Exagen Inc. (XGN), reported a sale of 11,430 shares of common stock.
• The transaction occurred on February 24, 2026, at a price of $3.61 per share.
• The sale was non-discretionary, mandated by the Issuer to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• Following the reported transaction, John Aballi directly beneficially owns 702,997 shares of common stock.
• Additionally, 40,401 shares are indirectly beneficially owned by his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax purposes related to RSU vesting, not reflecting a change in the CEO's investment outlook or the company's operational performance.

Management Comments

• The sale represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units.
• The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.

Industry Context

StockSavvy.ai notes that sales of shares to cover tax withholding obligations upon the vesting of restricted stock units are a common and routine occurrence for executives across various industries. Such transactions are typically not indicative of a change in management's sentiment towards the company's prospects but rather a standard part of equity compensation plans.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes, not signaling a change in management's confidence or company fundamentals.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.

Key Dates

Recommendation

The transaction is a routine, non-discretionary sale of shares to cover tax obligations related to RSU vesting. It does not reflect a change in the CEO's confidence in the company or its future prospects, thus it has no material impact on the investment thesis. A 'hold' recommendation is appropriate as this event does not provide new information to alter an existing investment decision.

Keywords

EXAGEN, XGN, Form 4, Insider Transaction, Stock Sale, CEO, RSU, Tax Withholding